Impact of tricuspid valve regurgitation on intermediate outcomes of degenerative mitral valve surgery Feb. 06, 2023 Overview Show transcript Overview Juan A. Crestanello, M.D., is a cardiovascular surgeon and department chair of Cardiovascular Surgery at Mayo Clinic in Rochester, Minnesota. Dr. Crestanello, who specializes in surgery for valvular heart disease, discusses the impact of tricuspid valve regurgitation on intermediate outcomes of degenerative mitral valve surgery. Receive Mayo Clinic news in your inbox. Sign up Related ContentVideoRobotic mitral valve repair: A decade of experience with echocardiographic follow-upVideoClinical outcomes of mitral valve repair for degenerative mitral regurgitation in older patientsVideoMitral valve repair versus replacement VID-20548575 Medical Professionals Impact of tricuspid valve regurgitation on immediate outcomes of degenerative mitral valve surgery